hematopoietic


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to hematopoietic: hematopoietic system, hematopoietic tissue, Hematopoietic Organs, Hematopoietic stem cell transplantation, Hematopoietic cells

he·ma·to·poi·e·sis

 (hē′mə-tō-poi-ē′sĭs, hĭ-măt′ə-) also he·mo·poi·e·sis (hē′mə-poi-ē′sĭs)
n.
The formation of blood or blood cells in the body.

he′ma·to·poi·et′ic (-ĕt′ĭk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.hematopoietic - pertaining to the formation of blood or blood cells; "hemopoietic stem cells in bone marrow"
Translations
hématopoïétique
References in periodicals archive ?
The Company intends to use these specific funds to study the use of adult stem cells from human adipose tissue for bone repair and for hematopoietic support in bone marrow transplantation.
Since the first close of our Series B, Cellerant has made significant progress in advancing our purified hematopoietic stem cell infusion, CLT-001, toward the clinic for sickle cell disease.
Pluristem's core technology is designed to expand Hematopoietic Stem Cells (HSC).
5,061,620) for the separation of human hematopoietic stem cells from bone marrow and for their cellular composition.
Until now the field of bone marrow transplantation has been limited to procedures and technologies that expand hematopoietic stem cells only.
Critical shortfall in the supply of matched tissue for transplantation creates an urgent need for alternative sources of hematopoietic stem cells (HSCs).
Chairman Max Link said, "This is the first of, we hope, many collaborations we will establish with our new partner and complements our already extensive R&D portfolio of hematopoietic growth factors, which includes granulocyte-macrophoge colony stimulating factor (GM-CSF), Interleukin 3 (IL-3), Interleukin 6 (IL-6) and Leukemia Inhibitory Factor (LIF).
Zami Aberman, CEO, stated: "Pluristem's novel approach has literally reinvented the field of bone marrow transplantation which until now has been limited to procedures and technologies that expand hematopoietic stem cells only.
In the March 15 issue of Blood, SyStemix scientists reported new data supporting that the company's proprietary SCID-hu mouse provides a useful and unique preclinical model to assess the in vivo effects of human hematopoietic growth factors as novel therapeutics for the human blood forming system, otherwise known as the hematopoietic system.
to form a 50/50 joint venture whose primary mission will be to research and develop hematopoietic cell-based, somatic gene therapies against HIV infection.
based in Palo Alto, is primarily engaged in the development of cellular processes and products based on human hematopoietic stem cells, human megakaryocytes and megakaryocyte progenitors.
The companies' other collaboration, in therapeutic antiviral agents for HIV infection, and their partnership, Progenesys, in hematopoietic cell-based, somatic gene therapies against HIV infection, are unaffected.